P&T Portfolio: Raptiva

Article

Raptiva for treatment of adult patients (18 years or older) with chronic, moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.